Ledger.Open graph →

SEC Form D · filed September 13, 2022

Neurolens, Inc

Offering

$67.6M

Sold

$67.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

COPPELL, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Davis Corley · Coppell, TXExec · Director J. Andy Corley · Coppell, TXDirector Pierre Bertrand · Coppell, TXExec William Link · Coppell, TXDirector Tom Finzi · Coppell, TXDirector Das Narayandas · Coppell, TXDirector Danny Perales · Coppell, TXExec Steve Kirby · Coppell, TXDirector Akhilesh Pathipati · Coppell, TXDirector Jeffrey I. Goddard · Grand Cayman, Cayman IslandsDirector Connor Clancy · Dublin, IrelandDirector Robert Keough · CHICAGO, ILExec · Director Marlon Smith · CHICAGO, ILDirector Erik Volfing · Englewood Cliffs, NJExec 1031CF Portfolio 4 ST LLC · Irvine, CADirector Sarah Niyogi · SAN BRUNO, CAExec Taiyo Fund Management LLC · Kirkland, WADirector Aric Plumley · Coppell, TXExec Eric Bednarski · Boston, MADirector Christina R. Erickson · BOSTON, MADirector Ellen Hall · BOSTON, MADirector Simon R. Fisk · BOSTON, MADirector Eric O. Ikauniks · Boston, MADirector Thomas O. Rodes · Boston, MADirector Scott T. Ford · Little Rock, ARExec · Director Ashley K. Northgrave · St. Peter Port, Y7Exec Chet K. Pohl · St. Peter Port, Y7Exec Akhilesh Pathipati · Coppell, TXDirector Aric Plumley · Coppell, TXExec Eric Bednarski · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗